Oct 16, 2024 9:15am EDT FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office
Oct 11, 2024 9:31am EDT FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit
Sep 12, 2024 9:31am EDT FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology
Sep 06, 2024 9:31am EDT FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Aug 20, 2024 9:31am EDT FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
Jun 25, 2024 9:31am EDT FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology